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IT has been reported by Miller, Grant and Roe (1963) that tumours induced by
benzpyrene applied to the skin, arise earlier in mice thymectomized at birth, than
in sham- or non-thymectomized mice. Similar results have been obtained by
Grant and Miller (1965) with mice injected with 20-methylcholanthrene (MeCh).
The present experiment has been undertaken to test the effect of administra-
tion of neonatal thymus tissue on the induction of lung tumours by DMBA in
new-born mice.
MATERIALS AND METHODS
Strain A mice, bred in this laboratory by selective brother-sister mating, were
used. They were divided into three groups with fifteen mice in each group; ten
females and five males.
Group 1.-Each mouse received one subcutaneous injection in the scapular
region of 30 ,ug. of DMBA in 15 ,l. of 3% aqueous gelatine solution, when less
than twelve hours old.
Group 2.-Each mouse received fortnightly intraperitoneal injections of
thymus tissue from mice in the neonatal period (3 to 5 days old). Each injection
was equivalent to one thymus macerated in 0-15 ml. of normal saline. A total
of twelve injections was given to each mouse, starting at 14 days of age.
Group 3.-Each mouse received one subcutaneous injection in the scapular
region of30 ,ug. ofDMBA in 15 ,u. of3% aqueousgelatine solution, when less than
twelve hours old. This was followed by fortnightly intraperitoneal injections of
thymus tissue from mice in the neonatal period (3 to 5 days old). Each injection
was equivalent to one thymus macerated in 0-15 ml. ofnormal saline. A total of
twelve injections was given to each mouse, starting at 14 days ofage.
All surviving animals were killed at 52 weeks and abnormal tissues found at
post mortem in these animals and also those dying earlier, were fixed and sectioned
for microscopical examination.
RESULTS
A number of mice died before six weeks of age and were replaced. Mortality
was higher in thymus injected animals, possibly due to repeated operative trauma.
The DMBA and the DMBA + thymus treated mice did not differ appreciably in
size from normal mice, but the group treated with thymus alone showed a marked
increase in general body size. The same results were obtained in both sexes.THYMUS AND DMBA LUNG TUMOUR INDUCTION
Mice treated with DMBA only.-Four mice died between 30 weeks with five
adenomata and 45 weeks with multiple adenomata of 1 to 3 mm. in diameter.
The remaining eleven mice, killed at 52 weeks had multiple or confluent adenomata
up to 3 mm. in diameter; four mice also had carcinomata of the lung ensuing in
adenomata and one fibrosarcoma was observed at the site ofinjection.
Mice receiving thymus injections only.-Seven mice died between 15 and 45
weeks for no apparent cause and had no adenomata. The remaining eight mice
were killed at 52 weeks and only one was found with two 1 mm. size adenomata,
others were without visible lesions. These mice had increased markedly in body
size and post mortem examination also showed a thick deposit of subcutaneous
fat.
Mice injected withDMBAfollowed by thymus injections.-Six mice died between
20weeks with two adenomata and 48 weeks with multiple adenomata of 1 to 7 mm.
in diameter. The remaining nine mice killed at 52 weeks, all had confluent
adenomata 5 to 7 mm. in diameter. The largest adenomata occupied whole lung
lobes and were roughly spherical in shape. All of these nine mice had lung carci-
nomata ensuing in adenomata, two had enlarged thymus glands and some spleens
were much reduced in size.
DISCUSSION
It is recognized that a variety of carcinogenic agents depress various types of
immune response (Linder, 1962) and it was suggested by Osoba and Miller (1963)
that a humoral factor from the thymus controls the development ofimmunological
competence. It would seem possible that the injections of neonatal thymus
would strengthen the immunological potential ofthe animal and might reduce the
activity of a chemical carcinogen. This was suggested by Maisin, who found a
reduction in the skin tumour incidence, induced by painting of 20-MeCh, by
implantation of thymus tissue (1963) or by injections of thymus homogenate
(1964a) and thymus supernatant or sediment (1964b).
The results in the present experiment do not confirm these observations in the
case of subcutaneous injections of carcinogen to new-born mice. Instead, they
suggest that injections ofneonatal thymus actually intensify the action ofDMBA
onthelungs ofstrainA mice. The adenomata are both larger and more numerous.
There are also more carcinomata per lung as compared with the DMBA group.
Compare Fig. 1, 2 and 3, 4.
Because neonatal thymectomy generally impairs the development of the
lymphatic system, and also retards normal growth (Miller, 1961) it is not surprising
that periodic injections of syngeneic thymic tissue should boost growth-rate and
ultimate size. It has been proposed (Burwell, 1963; Burch and Burwell, 1965)
that the primary and intrinsic function ofthe lymphoid system is that of growth-
control. In this new theory, the thymus is regarded as the first relay station in a
series of feedback controls (Burch and Burwell, 1965). The present results are
consistent with this view and they indicate that the artificial introduction of
syngeneic lymphoid mitogenic effectors into an arimal can override the normal
homeostatic controls ofgrowth.
However, the situation is clearly complex because thymectomy can also
accelerate the appearance of tumours induced by chemical carcinogens (Miller,
Grant and Roe, 1963; Grant and Miller, 1965). Apparently, two different mecha-
nisms can produce the same end result. Where the thymectomized animal is
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concerned, it is conceivable that the predominant effect is a weakening of the
immune defence against an auto-antigenic tumour, which therefore grows faster
than in the normal animal. In the animal with thymic supplement, the faster
growth-rate of normal tissues may also hasten the appearance of neoplastic cells.
This effect would appear to more than offset any enhancement there may be of a
hypothetical defence mechanism against the growing tumour.
SUMMARY
Strain A mice were used in all groups.
Group 1: A single subcutaneous injection of 30 ,ug. of DMBA was given to
new-born mice. All the mice developed pulmonary adenomata and four had
carcinomata.
Group 2: Intraperitoneal injections were given fortnightly ofneonatal thymus.
All the animals which died or were killed were without any lesions, except for one
52 weeks old mouse which developed two small adenomata. All mice increased in
body size.
Group 3: A single subcutaneous injection of 30 ,ug. of DMBA was given to
new-born mice, followed by fortnightly intraperitoneal injections of neonatal
thymus. All animals developed adenomata and nine had carcinomata of the
lungs.
From the results of the present experiment, it is evident that injections of
neonatal thymus intensify the action ofDMBA on the lungs ofstrain A mice.
This evidence also supports the theory that the thymus is involved in growth-
control.
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EXPLANATION OF PLATES
FIG. 1.-Mouse lung, 52 weeks after receiving one subcutaneous injection of DMBA when
new-born. x 4-3.
FIG. 2.-Mouse lung, 52 weeks after receiving one subcutaneous injection of DMBA when
new-born, followed by fortnightly intraperitoneal injections of neonatal thymus tissue.
x 4-3.
FIG. 3.-Histological section of DMBA-treated mouse lung after 52 weeks. x 8.
FIG. 4.-Histological section of DMBA + thymus-treated mouse lung after 52 weeks. x 8.BRITISH JOURNAL OF CANCER.
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